Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

Clinical trial NCT06940154 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06940154
Sponsor: Connect Biopharm LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COPD Acute Exacerbation

Start date: 2025-08-12
Primary completion: 2026-07-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.